science
This drug delayed rheumatoid arthritis for years after treatment ended
Why this matters: new research or scientific developments with potential real-world impact.
A promising new study suggests rheumatoid arthritis may not be as inevitable as once thought for people at high risk. Researchers found that just one year of treatment with the immune-targeting drug abatacept delayed the onset of rheumatoid arthritis by up to four years, with benefits lasting long a
Read full story on Science Daily → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Science Daily alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop